News

Researchers from QIMR Berghofer Medical Research Institute have developed a prototype test that can help identify if patients with deadly metastasised melanoma are likely to benefit from immunotherapy.

After hearing of cases where women had surgery scheduled after wrongly being told they had very rare genetic variations in the gene BRCA1 that could significantly increase risk of breast cancer, researchers conducted a large-scale analysis of the technology used. They found that it wrongly identified the presence of very rare genetic variants in the majority of cases.

Engineers have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer's levels of glucose as well as lactate, alcohol and caffeine.

New technology has been developed that can detect small fragments of DNA in blood serum, using a portable, smartphone-based microscope.

The Wyss Institute’s eRapid electrochemical sensor technology now enables sensitive, specific, and multiplexed detection of blood biomarkers at low cost with potential for many clinical applications.

A liquid biopsy examining blood or urine can help gauge the effectiveness of therapy for colorectal cancer that has just begun to spread. Such a biopsy can detect lingering disease and could assist in deciding whether a patient requires further treatment.

One in twenty high-risk cancer patients face the possibility of developing heart failure from certain cancer therapies. Results of a clinical trial point to the benefit of using a more sensitive test to detect heart function issues early, so cancer patients don't have to fight heart failure too.

For some 15,000 years, dogs have been our hunting partners, workmates, helpers and companions. Could they also be our next allies in the fight against COVID-19? A new review paper adds to the consensus that trained medical scent dogs can effectively be used for screening individuals who may be infected with the COVID-19 virus.

The small, mobile laboratory could provide rapid coronavirus test results in regions of Africa where testing facilities and medical infrastructure fall far short of European standards.

Researchers have developed a second-generation lung-on-chip model with life-size dimension alveoli in a stretchable membrane, made of purely biological material. The new model reproduces key aspects of the lung tissue architecture not found in previous lungs-on-chip, opening up new possibilities for basic pneumological research, understanding lung pathologies, drug screening and precision medicine.